Ddfg, Inc Johnson & Johnson Transaction History

Ddfg, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$144.38 - $157.78 $28,298 - $30,924	-196 Reduced 11.79%	1,466 $214 Million
Q1 2024 May 02, 2024	SELL	$155.22 - $162.74 $16,453 - $17,250	-106 Reduced 6.0%	1,662 $263 Million
Q4 2023 Feb 05, 2024	BUY	$145.6 - $158.88 $873 - $953	6 Added 0.34%	1,768 $277,000
Q3 2023 Nov 02, 2023	BUY	$155.75 - $174.48 $778 - $872	5 Added 0.28%	1,762 $274 Million
Q2 2023 Aug 09, 2023	SELL	$154.35 - $166.11 $27,165 - $29,235	-176 Reduced 9.11%	1,757 $291 Million
Q1 2023 May 05, 2023	SELL	$151.05 - $180.26 $9,214 - $10,995	-61 Reduced 3.06%	1,933 $300 Million
Q4 2022 Mar 01, 2023	BUY	$160.2 - $179.79 $319,438 - $358,501	1,994 New	1,994 $352 Million

4,272

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Ddfg, Inc, based on Form 13F filings with the SEC.

Stay updated on Ddfg, Inc with notifications on news.